taurine has been researched along with Bipolar Disorder in 10 studies
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data were collected during an 8-week randomized controlled trial of acamprosate for individuals with co-occurring bipolar disorder and alcohol dependence (n = 30)." | 9.16 | Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. ( Brady, KT; Brown, DG; Chiuzan, C; DeSantis, SM; Prisciandaro, JJ; Tolliver, BK, 2012) |
| "Acamprosate was well-tolerated, with no worsening of depressive or manic symptoms, and appeared to confer some clinical benefit in study completers in the last two weeks of the trial." | 6.77 | A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. ( Brady, KT; Brown, DG; Desantis, SM; Prisciandaro, JJ; Tolliver, BK, 2012) |
| "Data were collected during an 8-week randomized controlled trial of acamprosate for individuals with co-occurring bipolar disorder and alcohol dependence (n = 30)." | 5.16 | Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. ( Brady, KT; Brown, DG; Chiuzan, C; DeSantis, SM; Prisciandaro, JJ; Tolliver, BK, 2012) |
| "Acamprosate was well-tolerated, with no worsening of depressive or manic symptoms, and appeared to confer some clinical benefit in study completers in the last two weeks of the trial." | 2.77 | A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. ( Brady, KT; Brown, DG; Desantis, SM; Prisciandaro, JJ; Tolliver, BK, 2012) |
| "Comorbidity of alcohol abuse and dependence with bipolar disorders is high." | 1.38 | Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.). ( Preuss, UW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geoffroy, PA | 1 |
| Gottlieb, J | 1 |
| Wu, TN | 1 |
| Chen, CK | 1 |
| Lee, CS | 1 |
| Wu, BJ | 1 |
| Sun, HJ | 1 |
| Chang, CH | 1 |
| Chen, CY | 1 |
| Wu, LS | 1 |
| Cheng, AT | 1 |
| Icro Maremmani, AG | 1 |
| Bacciardi, S | 1 |
| Rovai, L | 1 |
| Rugani, F | 1 |
| Massimetti, E | 1 |
| Gazzarrini, D | 1 |
| Dell'Osso, L | 1 |
| Maremmani, I | 1 |
| Prisciandaro, JJ | 3 |
| Brown, DG | 3 |
| Brady, KT | 3 |
| Tolliver, BK | 3 |
| DeSantis, SM | 2 |
| Chiuzan, C | 1 |
| Preuss, UW | 1 |
| Fekkes, D | 2 |
| Pepplinkhuizen, L | 2 |
| Verheij, R | 1 |
| Bruinvels, J | 2 |
| Machado-Vieira, R | 1 |
| Viale, CI | 1 |
| Kapczinski, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics[NCT03220776] | Phase 2 | 54 participants (Actual) | Interventional | 2017-08-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Concentrations of GABA+, referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy (i.e., MEGA-PRESS). (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 3.90 |
| Gabapentin | 3.93 |
| Placebo Oral Tablet | 3.73 |
Concentrations of Glx (i.e., glutamate + glutamine), referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy. (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 21.59 |
| Gabapentin | 21.69 |
| Placebo Oral Tablet | 22.25 |
3 trials available for taurine and Bipolar Disorder
7 other studies available for taurine and Bipolar Disorder
| Article | Year |
|---|---|
Activity, cognition, and emotion: Three dimensional pillars of the natural presentations of mood disorders enriched by the "sleep" fourth dimension (ACES).
Topics: Bipolar Disorder; Cognition; Emotions; Humans; Mood Disorders; Sleep; Taurine | 2020 |
Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression.
Topics: Asian People; Bipolar Disorder; Carboxy-Lyases; Case-Control Studies; Cell Line, Tumor; gamma-Aminob | 2019 |
Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.
Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Bipolar Disorder; Female; Huma | 2014 |
Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.).
Topics: Alcohol Drinking; Alcoholism; Behavior, Addictive; Bipolar Disorder; Depression; Female; Humans; Mal | 2012 |
Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis.
Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Female; Humans; Male; Methionine; Middle Aged; Psy | 1994 |
Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol.
Topics: Adult; Bipolar Disorder; Caffeine; Humans; Inositol; Male; Taurine | 2001 |
Derangement of one-carbon metabolism in episodic schizoaffective psychoses.
Topics: Bipolar Disorder; Carbolines; Carbon; Glycine; Humans; Schizophrenia; Serine; Taurine | 1988 |